You are here

Priority Government Relations Issues

The United States Congress and federal regulatory agencies, such as the Centers for Medicare and Medicaid Services (CMS) and the Agency for Healthcare Research and Quality, make many critical decisions on issues that have an impact on vascular surgeons and their patients. The Society for Vascular Society® (SVS) Government Relations Committee monitors these issues and oversees SVS lobbying efforts to ensure the interests of the vascular surgery specialty are represented in critical legislative and regulatory decisions.

Medicare Access and CHIP Reauthorization Act (MACRA)

MACRA, signed into law in April 2015, replaced the Sustainable Growth Rate formula for updates to the Medicare physician fee schedule.

Phasing into a new system will occur from 2015-2019, with a 0.5 percent base update in years 2016-19 (a separate 0.5 percent increase went into effect in July 2015). 

On Jan. 1, 2019, new payment models begin:

  • Merit-Based Incentive Payment System (MIPS)
  • Alternative Payment Models (APMS)

MACRA likely will have a greater influence on medical practice than any other recent law. SVS, along with other specialty societies, will be a key player in the law’s implementation. SVS also will be educating and supporting its members during the transition.

In November 2015, SVS submitted comments to the Centers for Medicare & Medicaid Services about MACRA. The comments concerned implementation of MIPS and APMs, including possible APMs for vascular surgery.  The SVS also submitted follow-up comments in June 2016 on the new payment models  The comments are at the link below:

Comments to CMS, Nov. 17, 2015

Letter to CMS on Proposed Rule, June 27, 2016

Quality Improvement and Reporting: A Survival Guide for Your Practice, Vascular Annual Meeting, June 11, 2016


On July 22, 2015, the Centers for Medicare and Medicaid Services (CMS) convened a panel of the Medicare Evidence Development and Coverage Advisory Committee (MEDCAC) on lower extremity peripheral artery disease (PAD). 

The purpose of MEDCAC is to examine scientific evidence of existing interventions that aim to improve health outcomes in the Medicare population and address areas where evidence gaps exist. MEDCAC does not make coverage determinations, but the panel’s advice could determine the basis for future determinations by CMS on Medicare coverage of PAD. 

The panel focused on three categories along the disease progression continuum: asymptomatic, intermittent claudication and critical limb ischemia. Clinical outcomes of interest relating to PAD include: reduction in pain, avoidance of amputation, improvement of quality of life and/or functional capacity including walking distance, wound healing, avoidance of cardiovascular events and avoidance of harms from interventions. 

Two speakers who were invited to present at the MEDCAC meeting were SVS members Jack Cronenwett, MD who spoke on the Vascular Quality Initiative (VQI)/Using Registries to Provide Clinical Evidence and Matthew Menard, MD who spoke on the Best Endovascular vs. Best Surgical Therapy in Patients with Critical Limb Ischemia, known as the BEST-CLI Trial. 

Also, three SVS members were chosen to present public comments: President-Elect Ron Fairman, MD; Michael Conte, MD; and Joseph Mills, MD. Dr. Fairman provided background on SVS, vascular surgery and the VQI; Dr. Conte discussed the 2015 SVS Clinical Practice Guideline on PAD, which addresses evaluation and management of asymptomatic PAD and intermittent claudication and Dr. Mills focused on critical limb ischemia and the SVS Lower Extremity Threatened Limb Classification System: Risk Stratification based on Wound, Ischemia and Foot Infection (WIFI).

AAA Screening

The Screening Abdominal Aortic Aneurysms Very Efficiently Act (SAAAVE) became effective on January 1, 2007. It provides a one-time AAA ultrasound screening for at-risk Medicare beneficiaries as part of the Welcome to Medicare Physical Exam, now called the Annual Wellness Visit. Because of barriers to this screening, such as a required referral, fewer than 10,000 beneficiaries were screened for AAA in 2007. Through the health care reform process, SVS lobbied to increase the number of Medicare beneficiaries who take advantage of this benefit. As a result, the Disease Prevention section of the health care reform law includes authorization for the US Department of Health and Human Services Secretary to modify coverage of existing preventive services if the changes are consistent with United States Preventive Services Task Force recommendations. In addition, co-pays were eliminated in Medicare for this screening and reimbursement was increased. 

Administrative Rules

SVS comments on proposed and final rules that have an impact on vascular surgeons and their patients. The rules are drafted by U.S. federal agencies typically following the enactment of legislation and are posted in the Federal Register. SVS always comments on Medicare Physician Fee Schedule rules that are drafted by CMS.

Health Care Reform

The U.S. House of Representatives passed the Senate health care reform bill and it was signed into law by U.S. President Barack Obama on March 23, 2010. The House passed a “fixes” reconciliation bill on March 23, 2010. The Senate made some minor changes to the reconciliation bill and passed it on March 25, 2010. Because of the changes, the House had to again vote on the bill, which it passed on March 25, 2010 and the President signed that bill into law on March 30, 2010. Many of the provisions will not take effect until 2014. Despite being law, SVS will continue to advocate against provisions which are problematic, such as the unelected, unaccountable Independent Payment Advisory Board.

Communications sent to U.S. leaders include: 


Across-the-board cuts to imaging were included in the 2005 Deficit Reduction Act (DRA), which became effective on January 1, 2007. SVS was successful in removing five physiologic vascular lab codes from DRA and averting additional cuts in the health care reform law. SVS also supports accreditation for vascular labs and credentialing for vascular lab staff.  SVS continues to monitor legislation for any proposed cuts to vascular imaging. 

MedPAC’s June 2011 Recommendations to Congress on Imaging Create Concern

The Medicare Payment Advisory Commission's (MedPAC) Annual Report to Congress includes a recommendation that seeks to penalize physicians when they order tests for their patients and then perform and interpret them in their own offices. Other imaging recommendations include extension of the current across-the-board multiple procedure payment reduction to physician interpretation and mandatory prior authorization for advanced diagnostic services. SVS has signed onto a statement opposing these recommendations. Also, the complete MedPAC report can be accessed online. The good news is that MedPAC is no longer recommending the elimination of the Stark in-office ancillary services exception.

Physician Reimbursement

After 10 years of advocacy by SVS staff and members, the Sustainable Growth Rate (SGR) formula was repealed, Medicare physician payment was reformed and elimination of the 10- and 90-day global surgical packages was prevented by Congress in the Medicare Access and CHIP Reauthorization Act (MACRA).  This legislation was enacted by Congress and signed by President Obama in April 2015.  The law creates two payment alternatives, the Merit-based Incentive Payment System (MIPS) and Alternative Payment Models (APMs), which are voluntary and begin in 2019.  Both systems will provide bonuses to physicians who successfully participate in them.